会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Molecular identification of Aspergillus species
    • 曲霉菌的分子鉴定
    • US07871779B2
    • 2011-01-18
    • US12115493
    • 2008-05-05
    • Christine J. MorrisonHans Peter Hinrikson
    • Christine J. MorrisonHans Peter Hinrikson
    • C12Q1/68C12P19/34C07H21/04
    • C12Q1/6895
    • Novel techniques for the detection of Aspergillus in samples are disclosed. These techniques relate to PCR amplification and/or detection of Aspergillus ITS1 rDNA sequences, and the identification of particular species of Aspergillus by detecting differences in the ITS1-V1, ITS-V2, ITS-V3, ITS-V4, and ITS-V5 nucleic acid sequences of Aspergillus. The highly variable regions of the ITS1 rDNA sequences are particularly useful in distinguishing, for example, Aspergillus clavatus, Aspergillus granulosus, Aspergillus sydowii, Aspergillus flavipes, Aspergillus restrictus, Aspergillus versicolor, Aspergillus wentii, and Aspergillus chevalieri. In particular embodiments, the sequence differences are also able to distinguish among variants of particular species, such as Aspergillus granulosus CBS 119.5A, Aspergillus granulosus strain NRRL 1932, Aspergillus sydowii strain NRRL 250, Aspergillus sydowii strain NRRL 4768, Aspergillus sydowii strain CUHI, Aspergillus sydowii strain CUH2, Aspergillus sydowii strain CUH7, and Aspergillus sydowii strain CUH8.
    • 公开了用于检测样品中曲霉菌的新技术。 这些技术涉及通过检测ITS1-V1,ITS-V2,ITS-V3,ITS-V4和ITS-V5核酸中的差异来鉴定曲霉ITS1 rDNA序列的PCR扩增和/或检测,并鉴定特定的曲霉种 曲霉酸序列。 ITS1 rDNA序列的高度可变区特别可用于区分例如曲霉菌(Aspergillus clavatus),粒细菌(Aspergillus granulosus),曲霉(Aspergillus sydowii),曲霉(Aspergillus flavipes),限制曲霉(Aspergillus restrictionus),曲霉(Aspergillus versicolor),曲霉(Aspergillus goii)和曲霉(Aspergillus chevalieri)。 在特定的实施方案中,序列差异也能够区分特定种类的变体,例如粒细菌芽孢杆菌CBS 119.5A,粒细菌菌株NRRL 1932,曲霉菌株NRRL 250,曲霉菌菌株NRRL 4768,曲霉菌菌株CUHI,曲霉属(Aspergillus sydowii) sydowii菌株CUH2,曲霉菌菌株CUH7和曲霉菌菌株CUH8。
    • 5. 发明授权
    • Peptide vaccines against group A streptococci
    • 针对A组链球菌的肽疫苗
    • US07407664B2
    • 2008-08-05
    • US10477955
    • 2002-05-20
    • Bernard W. BeallGeorge M. CarloneJacquelyn S. SampsonEdwin W. Ades
    • Bernard W. BeallGeorge M. CarloneJacquelyn S. SampsonEdwin W. Ades
    • A61K39/09A61K39/00C07H21/04C12N15/00
    • A61K39/092A61K39/00C07K14/001C07K14/315C07K2319/00
    • This invention, in one aspect, relates to synthetic immunoreactive peptides. These peptides are approximately 20-25 amino acids in length which are portions of the N termini of the M proteins of the most prevalent United States (U.S.) Group A Streptococcus (GAS) serotypes. At least some of the synthetic peptides can be recognized by M type-specific antibodies and are capable of eliciting functional opsonic antibodies and/or anti-attachment antibodies without eliciting tissue cross-reactive antibodies. In another aspect, it relates to compositions or vaccines comprising these synthetic serotype-specific peptides, including polypeptides and proteins. The invention may also be isolated antibodies which are raised in response to the peptides, compositions or vaccines. The invention further relates to kits for using the peptides, compositions, or antibodies. In still further aspects, the invention also relates to methods for using the peptides, compositions, vaccines, or antibodies and methods for tailoring vaccines.
    • 本发明在一个方面涉及合成免疫反应肽。 这些肽的长度约为20-25个氨基酸,它们是最流行的美国(A)链球菌(GAS)血清型的M蛋白的N末端的部分。 至少一些合成肽可被M型特异性抗体识别,并且能够引发功能性调理抗体和/或抗附着抗体而不引发组织交叉反应性抗体。 另一方面,本发明涉及包含这些合成血清型特异性肽(包括多肽和蛋白质)的组合物或疫苗。 本发明还可以是响应于肽,组合物或疫苗引起的分离的抗体。 本发明还涉及使用肽,组合物或抗体的试剂盒。 在另外的方面,本发明还涉及使用肽,组合物,疫苗或抗体的方法和用于定制疫苗的方法。